---
figid: PMC3050040__nihms-274495-f0001
figtitle: Major kinase signaling cascades involved in drug addiction
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3050040
filename: nihms-274495-f0001.jpg
figlink: /pmc/articles/PMC3050040/figure/F1/
number: F1
caption: Diagram of the major kinase signaling cascades involved in drug addiction.
  Dopamine receptors activate heterotrimeric G-proteins. D1 receptors activate stimulatory
  Gs, D2 receptors activate inhibitory Gi/o, and D1/D2 heteromers activate stimulatory
  Gq. Cannabinoid CB1 receptors and opioid receptors also activate Gi/o. Gαs and Gβγ
  released from Gi/o activate adenylyl cyclase, leading to increased cAMP levels which
  activate PKA. Induction of the transcription factor deltaFosB increases Cdk5 expression.
  Differential phosphorylation of DARPP-32 by PKA and Cdk5 inhibits or facilitates
  PKA signaling. Gβγ also activates GIRK channels leading to inhibition of excitability.
  Gαq and Gβγ activate PLC and PLD, leading to the activation of PKC. Several downstream
  PKA and PKC targets are listed at the bottom. Activation of ionotropic glutamate
  receptors and L-type calcium channels increases intracellular calcium levels, leading
  to activation of the Ras-Raf-MEK-ERK pathway. Activation of TrkB receptors also
  activates the ERK pathway, leading to the phosphorylation of transcription factors
  CREB and Elk-1. Examples of cross-talk between the PKA, PKC, Cdk5, and ERK signaling
  pathways are illustrated. This diagram is a simplification that does not incorporate
  differential expression of kinases in different brain regions and cell types.
papertitle: Protein Kinases and Addiction.
reftext: Anna M. Lee, et al. Ann N Y Acad Sci. ;1141:22-57.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9398117
figid_alias: PMC3050040__F1
figtype: Figure
redirect_from: /figures/PMC3050040__F1
ndex: fa328ea6-df01-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3050040__nihms-274495-f0001.html
  '@type': Dataset
  description: Diagram of the major kinase signaling cascades involved in drug addiction.
    Dopamine receptors activate heterotrimeric G-proteins. D1 receptors activate stimulatory
    Gs, D2 receptors activate inhibitory Gi/o, and D1/D2 heteromers activate stimulatory
    Gq. Cannabinoid CB1 receptors and opioid receptors also activate Gi/o. Gαs and
    Gβγ released from Gi/o activate adenylyl cyclase, leading to increased cAMP levels
    which activate PKA. Induction of the transcription factor deltaFosB increases
    Cdk5 expression. Differential phosphorylation of DARPP-32 by PKA and Cdk5 inhibits
    or facilitates PKA signaling. Gβγ also activates GIRK channels leading to inhibition
    of excitability. Gαq and Gβγ activate PLC and PLD, leading to the activation of
    PKC. Several downstream PKA and PKC targets are listed at the bottom. Activation
    of ionotropic glutamate receptors and L-type calcium channels increases intracellular
    calcium levels, leading to activation of the Ras-Raf-MEK-ERK pathway. Activation
    of TrkB receptors also activates the ERK pathway, leading to the phosphorylation
    of transcription factors CREB and Elk-1. Examples of cross-talk between the PKA,
    PKC, Cdk5, and ERK signaling pathways are illustrated. This diagram is a simplification
    that does not incorporate differential expression of kinases in different brain
    regions and cell types.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ca
  - Nmdar2
  - Nmdar1
  - Pld
  - norpA
  - sl
  - Plc21C
  - ac
  - ras
  - Ras64B
  - Ras85D
  - Pp1alpha-96A
  - flw
  - br
  - Pp4-19C
  - Pp1-13C
  - Pp1-87B
  - PpD6
  - Raf
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Rap1
  - fzr
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Cdk5alpha
  - RpLP0
  - MED6
  - Dsor1
  - Mtk
  - Cdk5
  - Erk7
  - rl
  - CrebB
  - CrebA
  - Nach
  - nAChRalpha3
  - nAChRalpha7
  - nAChRbeta3
  - nAChRalpha6
  - nAChRalpha5
  - nAChRbeta1
  - nAChRalpha4
  - nAChRalpha1
  - nAChRalpha2
  - nAChRbeta2
  - NTRK2
  - GRIN1
  - GRIN2A
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - GRIN3A
  - GRIN3B
  - CNR1
  - GPLD1
  - PLD1
  - PLD2
  - PLD3
  - PLD4
  - PLD5
  - PLD6
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - KRAS
  - HRAS
  - NRAS
  - BRAF
  - PPA1
  - NPY4R
  - NPY4R2
  - ZHX2
  - ARAF
  - RAF1
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - LRPAP1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - FCN2
  - GCHFR
  - IL12A
  - CDK5R1
  - UPK3B
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PPP1R1B
  - CDK5
  - EPHB2
  - MAPK1
  - MAPK3
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - ELK1
  - KCNH4
  - KCNH8
  - CHRNA4
  - Dopamine D2
  - Thr
  - AMPA
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
